Background Patients with systemic sclerosis (SSc) are known to have an elevated risk for
cardiovascular diseases. Approximately 20-25% of all SSc patients have permanently …

The authors, who are well-respected researchers in the field of myositis, have done a good
job in conducting a small openlabel trial of RCI in the treatment of PM/DM using validated …

It seems most unusual that in a review of “all currently available treatments” for knee
osteoarthritis (OA) by 21 authorities and “two experts in the field of guidelines methodology” …

Background The Dutch cardiovascular risk management (CV-RM) guideline considers
rheumatoid arthritis (RA) an independent risk factor for cardiovascular disease (CVD), for …

Tan et al recently described a case of ''resistant giant cell arteritis''successfully treated with
etanercept. 1 Their patient, who had classical symptoms of polymyalgia rheumatica (PMR) …

I read with great interest the paper by van Sijl et al, 1 a 3-year longitudinal study by following
patients with rheumatoid arthritis (RA) to know the effect of the estimated renal function on …

Background: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by
endothelial dysfunction and progressive fibrosis leading to organ failure. The increasing …

Background Patients with rheumatoid arthritis (RA) are at an increased risk for developing
cardiovascular diseases. While advice regarding cardiovascular risk screening and …

The authors have also reported increased risk of DM in patients with RA who took
glucocorticoids (GCs) and statin therapy. Surprisingly, the HR of diabetes has been found to …

Background: Patients with lupus nephritis (LN) face 9x higher risk of premature
cardiovascular disease (CVD) compared to patients with systemic lupus without nephritis …